TCELS join hand Malaysia plans to sign an MOU on the development of vaccines- medical devices

Food and Healthcare Press Releases Thursday November 28, 2013 10:40
Bangkok--28 Nov--TCELS
TCELS forges an alliance with Malaysia and plans to sign an MOU on the development of vaccines medicine and production of medical devices.

Malaysia’s bioeconomy is regarded to be the propelling force of the government’s business growth agenda and is predicted to boost the country’s wealth in 2020. Thailand too is moving forward to become Asia Pacific’s centre of excellence for life sciences.

Dr.Nares Damrongchai, CEO of Thailand Centre of Excellence for Life Sciences (TCELS) under the Ministry of Science and Technology said that TCELS’s representatives led by Somchai Tiamboonprasert, the Ministry of Science and Technology’s deputy permanent secretary and also TCELS’ board member, attended BioMalaysia 2013 organized at Johor Bahru to build up a network of life science contacts among Asia-Pacific countries.

According to Dr. Nares, BioMalaysia 2013 is a business affiliation of the government and private sectors as well as biotechnology entrepreneurs to form a connection among that related parties and to promote bioeconomy in Asia Pacific region. This year, representatives from over 10 countries participated in the programme and TCELS represented Thailand. In the Exhibition, TCELS representatives came up with life sciences innovation including rubber latex extraction and cell and gene therapy projects that grabbed the attention of Malaysian entrepreneurs and investors who showed interest in these projects.

Through this participation is BioMalaysia 2013, has forged a relationship with BiotechCorp, a Malaysian company that is formed by business collaboration between Malaysia’s Ministry of Finance, Ministry of Science, Technology and Innovation and Federal Lands Commission. This new alliance is making steady progress. A Memorandum of Understanding (MOU) is being prepared on the development of vaccines, production of medical devices and their testing before being used in clinics as well as human resource development.

In addition, an idea of seeking business partners to bring a business venture among Thai and Malaysian investors was also mentioned in the meeting. It is recommended that Thailand and Malaysia would run the programme on alternate year. BiotechCorp advised about forming an alliance to work on biotechnology and biofuel and working hand in hand with various sectors including Ministry of Science and Technology, National Science and Technology Development Agency (NSTDA) and Thailand Institute of Scientific and Technological Research (TISTR).

Dr. Nares pointed out that Malaysia has a firm economic base in the field of biotechnology as the country has a clear policy and well – defined goals to boost the bio- economy and develop strategies to support the industry. Malaysian government aims to achieve the goal of producing 3.6 billion ringgits of Gross Domestic Product (GDP) and generating 10.6 billion ringgits worth of investment and creating about 16,300 job opportunities by 2020. Organization for Economic Co-operation and Development (OECD) forecasts that Malaysia’s bio- economy will make up 2.7% of the world’s total GDP in 2030.

While, Thailand’s TCELS has a goal to be a centre of excellence of life sciences in the Asia Pacific region. To achieve this goal, the country is moving ahead with their plans to develop high quality academics, improve medical services and give support to medical devices industry. The development of medical robotics and cell therapy development is also TCELS another important strategy to achieve this goal.

Latest Press Release

Osotspa joins with Banphaeo Hospital to provide free surgeries to give sight back to patients with cataracts

Osotspa Public Company Limited has joined together with Banphaeo Hospital to give senior citizens and the underprivileged in remote areas who needed cataract surgery their sight back so they can resume living normal lives, an initiative that reflects the...

Financial year 2018: Boehringer Ingelheim grows and invests

- Well-filled research pipeline in oncology, fibrotic diseases, immunology and metabolic diseases - Operating growth outpaces the market in all businesses - Technical integration of the animal health business acquired in 2017 successfully completed The...

#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma#s Empowering Rosacea Awareness Month Social Media Campaign

As part of its ongoing commitment to raising awareness of rosacea and the hidden burden of the disease, Galderma is collaborating with top social media influencers this Rosacea Awareness Month, to encourage people with rosacea to speak up and share...

Galderma Marks Rosacea Awareness Month With New Insights Into Why Some Patients Are Self-treating and Launches Social Media Campaign to Reinforce Hidden Impact of the Disease

Galderma extends its commitment to understanding the beyond the visible impact of rosacea with new patient insights supporting healthcare professionals' understanding of patient behavior and revealing possible motivations for not reconsulting Building...

Sun Life Financial Asia Releases New Diabetes in Asia Report

More than 60% of diabetics live in Asia; Community-based approach needed to create opportunities for change A coordinated, community-based approach is essential to hold back the rising tide of diabetes in Asia, according to a new report from Sun Life...

Related Topics